PART IV
Item 15. Exhibits and Financial Statement Schedules
(a) The following documents are ﬁled as part of this report:
1. Financial Statements. The following Consolidated Financial Statements of Mineral Technologies Inc. and subsidiary
companies and Reports of Independent Registered Public Accounting Firm are set forth on pages F -2 to F-38.
Consolidated Balance Sheets as of December 31, 2016 and 2015
Consolidated Statements of Income for the years ended December 31, 2016, 2015 and 2014
Consolidated Statements of Comprehensive Income for the years ended December 31, 2016, 2015 and 2014
Consolidated Statements of Cash Flows for the years ended December 31, 2016, 2015 and 2014
Consolidated Statements of Shareholders' Equity for the years ended December 31, 2016, 2015 and 2014
Notes to the Consolidated Financial Statements
Reports of Independent Registered Public Accounting Firm
Management's Report on Internal Control Over Financial Reporting
2. Financial Statement Schedule. The following ﬁnancial statement schedule is ﬁled as part of this report:
Pagg
Schedule II - Valuation and Qualifying 8-1
All other schedules for which provision is made in the applicable accounting regulations of the SEC are not required under
the related instructions or are inapplicable and, therefore, have been omitted.
3. Exhibits. The following exhibits are ﬁled as part of, or incorporated by reference into, this report.
2.1 - Agreement and Plan of Merger, dated as of March 10, 2014, by and among Minerals
Technologies Inc., MA Acquisition Inc. and AMCOL International Corporation (1)
3.1 - Restated Certiﬁcate of Incorporation of the Company (2)
3.2 - By-Laws of the Company as amended and restated effective March 16, 2016 (3)
4.1 - Specimen Certiﬁcate of Common Stock (2)
10.1 - Asset Purchase Agreement, dated as of September 28, 1992, by and between Specialty
Refractories Inc. and Quigley Company Inc. (4)
10.1(a) - Agreement dated October 22, 1992 between Specialty Refractories Inc. and Quigley Company
Inc., amending Exhibit 10.1 (5)
10.1(b) - Letter Agreement dated October 29, 1992 between Specialty Refractories Inc. and Quigley
Company Inc., amending Exhibit 10.1 (5)
10.2 - Reorganization Agreement, dated as of September 28, 1992, by and between the Company and
Pﬁzer Inc. (4)
10.3 - Asset Contribution Agreement, dated as of September 28, 1992, by and between Pﬁzer Inc. and
Specialty Minerals Inc. (4)
10.4 - Asset Contribution Agreement, dated as of September 28, 1992, by and between Pﬁzer Inc. and
Barretts Minerals Inc. (4)
10.4(a) - Agreement dated October 22, 1992 between Pﬁzer Inc, Barretts Minerals Inc. and Specialty
Minerals Inc., amending Exhibits 10.3 and 10.4 (5)
10.5 - Employment Agreement, dated December 13, 2016, between the Company and Douglas T.
Dietrich (6) (+)
10.6 - Form of Employment Agreement between the Company and each of Brett Argirakis, Michael
A. Cipolla, Matthew E. Garth, Andrew Jones, Douglas W. Mayger, Thomas J. Meek, W. Rand
Mendez and DJ. Monagle, III (*) (+)
10.6(a) - Form of Employment Agreement between the Company and Jonathan J. Hastings (7) (+)
10.6(b) - Form of amendment to Employment Agreement between the Company and Jonathan J.
Hastings (8) (+)
10.6(c) - Form of Employment Agreement between the Company and Gary L. Castagna (9) (+)
10.7 - Severance Agreement between the Company and Douglas T. Dietrich (10) (+)
10.8 - Form of Severance Agreement between the Company and each of Brette Argirakis, Michael A.
Cipolla, Matthew E. Garth, Andrew Jones, Douglas W. Mayger, Thomas J. Meek, W. Rand
Mendez, and DJ. Monagle, III (*) (+)
10.8(a) - Form of Severance Agreement between the Company and Jonathan J. Hastings (11) (+)
48